Press Releases Oxford Biomedica Solutions Publishes Peer-Reviewed Journal Article On Novel Dual-Plasmid System, Resulting In Significantly Increased AAV Vector Productivity And Percentage Of Full Capsids Packaged June 8, 2023
Press Releases Oxford Biomedica Solutions to Present Company Capabilities and its Platform at American Society of Gene and Cell Therapy in Los Angeles May 9, 2023
Press Releases Oxford Biomedica Solutions forms new partnerships with three biotechnology companies December 14, 2022
Press Releases Oxford Biomedica Solutions signs agreement with new partner for AAV platform September 14, 2022
Press Releases Oxford Biomedica notes Homology Medicines’ quarterly report and confirms financials for Oxford Biomedica Solutions LLC are in line with expectations August 16, 2022
Press Releases Oxford Biomedica Solutions announces novel Dual Plasmid Transfection System, and has demonstrated suspension bioreactor titers above E15 vg/L, and chromatography purification achieving 90% fully intact vector May 6, 2022
Press Releases Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the US with Homology Medicines as 20% owner January 28, 2022